Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy

Retrieved on: 2022-09-07 11:08:24

Tags for this article:

Click the tags to see associated articles and topics

Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy. View article details on hiswai:

Excerpt

The deal marks an encouraging sign in what remains a difficult market for biotech startups, which have struggled to maintain their valuations.

Article found on: www.statnews.com